Kaken Pharmaceutical Co., Ltd. (KKPCF)
USD 24.01
(0.0%)
USD 24.01
(0.0%)
| Breakdown | 2024 | 2024 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 72.04 Billion | 475.99 Million | 624.61 Million | 678.54 Million | 826.58 Million | 850.76 Million |
| Cost of Revenue | 33.82 Billion | 223.46 Million | 285.19 Million | 310.4 Million | 361.11 Million | 366.71 Million |
| Gross Profit | 38.22 Billion | 252.53 Million | 339.42 Million | 368.13 Million | 465.47 Million | 484.04 Million |
| Operating Expenses | 29.02 Billion | 189.67 Million | 199.23 Million | 207.15 Million | 219.88 Million | 261.86 Million |
| Selling, General and Administrative Expenses | 16.16 Billion | 106.8 Million | 130.06 Million | 146.19 Million | 160.43 Million | 169.16 Million |
| Research and Development Expenses | 12.54 Billion | 82.87 Million | 69.17 Million | 60.95 Million | 59.45 Million | 92.7 Million |
| Other Expenses | 318 Million | 57 Million | 129 Million | 70 Million | 109 Million | 85 Million |
| Cost and Expenses | 62.53 Billion | 413.13 Million | 484.43 Million | 517.56 Million | 581 Million | 628.58 Million |
| Operating Income | 9.51 Billion | 62.85 Million | 140.18 Million | 160.97 Million | 245.58 Million | 222.18 Million |
| Interest Expense | 17 Million | 17 Million | 139.65 Thousand | 153.84 Thousand | 157.47 Thousand | 153.58 Thousand |
| Income Tax Expense | 1.77 Billion | 11.69 Million | 35.62 Million | 47.52 Million | 66.89 Million | 64.57 Million |
| Earnings before Tax | 9.79 Billion | 64.72 Million | 114.06 Million | 168.84 Million | 246.32 Million | 225.16 Million |
| Net Income | 8.02 Billion | 53.02 Million | 78.44 Million | 121.31 Million | 179.42 Million | 160.59 Million |
| Earnings Per Share Basic | 212.66 | 1.41 | 2.07 | 3.14 | 4.58 | 4.03 |
| Earnings Per Share Diluted | 212.66 | 1.41 | 2.07 | 3.14 | 4.58 | 4.03 |
| Weighted Average Shares Outstanding | 37.73 Million | 37.73 Million | 37.97 Million | 38.59 Million | 39.14 Million | 39.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.73 Million | 37.73 Million | 37.97 Million | 38.59 Million | 39.14 Million | 39.87 Million |
| Gross Margin | 0.53 | 0.53 | 0.54 | 0.54 | 0.56 | 0.57 |
| EBIT Margin | 0.17 | 0.17 | 0.26 | 0.27 | 0.33 | 0.29 |
| Profit Margin | 0.11 | 0.11 | 0.13 | 0.18 | 0.22 | 0.19 |
| EBITDA | 12.26 Billion | 81.04 Million | 19.55 Billion | 20.1 Billion | 28.92 Billion | 27.09 Billion |
| Earnings Before Tax Margin | 0.13 | 0.13 | 0.22 | 0.24 | 0.30 | 0.26 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 475.99 Million | 114.69 Million | 131.2 Million | 120.59 Million | 125.74 Million | 131.05 Million |
| Cost of Revenue | 223.46 Million | 59.44 Million | 59.35 Million | 55.91 Million | 56.07 Million | 63.36 Million |
| Gross Profit | 252.53 Million | 55.24 Million | 71.85 Million | 64.67 Million | 69.66 Million | 67.69 Million |
| Operating Expenses | 189.67 Million | 53.11 Million | 48.04 Million | 49.82 Million | 46.84 Million | 100.77 Million |
| Selling, General and Administrative Expenses | - | 26.41 Million | 28.45 Million | 28.82 Million | 28.83 Million | 29.42 Million |
| Research and Development Expenses | - | 26.69 Million | 19.58 Million | 20.99 Million | 18.01 Million | 71.34 Million |
| Other Expenses | 57 Million | 25 Million | 15 Million | 15 Million | 2 Million | 172 Million |
| Cost and Expenses | 413.13 Million | 112.55 Million | 107.39 Million | 105.74 Million | 102.92 Million | 164.13 Million |
| Operating Income | 62.85 Million | 2.13 Million | 23.81 Million | 14.85 Million | 22.82 Million | -33.08 Million |
| Interest Expense | 17 Million | 26.42 Thousand | 35.43 Thousand | 26.76 Thousand | 27.71 Thousand | 37.63 Thousand |
| Income Tax Expense | 11.69 Million | -5.12 Million | 6.76 Million | 4.34 Million | 6.51 Million | -15.91 Million |
| Earnings before Tax | 64.72 Million | 3.8 Million | 25.24 Million | 14.76 Million | 23.9 Million | -43.83 Million |
| Net Income | 53.02 Million | 8.91 Million | 18.47 Million | 10.42 Million | 17.38 Million | -27.91 Million |
| Earnings Per Share Basic | - | 0.24 | 0.49 | 0.28 | 0.46 | -0.74 |
| Earnings Per Share Diluted | - | 0.24 | 0.49 | 0.28 | 0.46 | -0.74 |
| Weighted Average Shares Outstanding | 37.73 Million | 37.73 Million | 37.86 Million | 37.73 Million | 37.47 Million | 37.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.73 Million | 37.73 Million | 37.86 Million | 37.73 Million | 37.47 Million | 37.47 Million |
| Gross Margin | 0.53 | 0.48 | 0.55 | 0.54 | 0.55 | 0.52 |
| EBIT Margin | - | 0.06 | 0.22 | 0.17 | 0.22 | -0.21 |
| Profit Margin | 0.11 | 0.08 | 0.14 | 0.09 | 0.14 | -0.21 |
| EBITDA | - | 6.58 Million | 28.56 Million | 19.97 Million | 27.27 Million | -28.02 Million |
| Earnings Before Tax Margin | 0.13 | 0.02 | 0.18 | 0.12 | 0.18 | -0.25 |
MLX
TGKN
SVB
BJC
SAMBANDAM
VIDE